Promoter hypermethylation of SHOX2 and SEPT9 is a potential biomarker for minimally invasive diagnosis in adenocarcinomas of the biliary tract.
about
RNA sequencing (RNA-Seq) of lymph node, spleen, and thymus transcriptome from wild Peninsular Malaysian cynomolgus macaque (Macaca fascicularis).Novel biomarkers and endoscopic techniques for diagnosing pancreaticobiliary malignancyProgress on the clinical application of the SEPT9 gene methylation assay in the past 5 years.
P2860
Promoter hypermethylation of SHOX2 and SEPT9 is a potential biomarker for minimally invasive diagnosis in adenocarcinomas of the biliary tract.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 December 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Promoter hypermethylation of S ...... rcinomas of the biliary tract.
@en
Promoter hypermethylation of S ...... rcinomas of the biliary tract.
@nl
type
label
Promoter hypermethylation of S ...... rcinomas of the biliary tract.
@en
Promoter hypermethylation of S ...... rcinomas of the biliary tract.
@nl
prefLabel
Promoter hypermethylation of S ...... rcinomas of the biliary tract.
@en
Promoter hypermethylation of S ...... rcinomas of the biliary tract.
@nl
P2093
P2860
P1433
P1476
Promoter hypermethylation of S ...... arcinomas of the biliary tract
@en
P2093
D Dietrich
G Kristiansen
H Matthaei
P Schaefer
P2860
P2888
P356
10.1186/S13148-016-0299-X
P577
2016-12-12T00:00:00Z
P6179
1006446667